Letters to the Editor
Letter to the Editor: Bipolar I Disorder Exacerbation and COVID-19 Vaccination: Correspondence
Funding/financial disclosures. The authors have no conflict of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2023;20(1–3):8. Dear Editor: We would like to discuss the article, “Bipolar I Disorder Exacerbation Following COVID-19 Vaccination,”1 wherein Guina et al1 described the cases of a […]
Letter to the Editor: Antipsychotics and Parkinson’s Disease: A Troubling Mix
Funding/financial disclosures. The authors have no conflict of interest relevant to the content of this letter. Our studies are supported by the following grants: Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES). Innov Clin […]
Letter to the Editor: Olanzapine-induced Endoplasmic Reticulum Stress Induces Atypical Diabetes and Diabetic Ketoacidosis
Funding/financial disclosures. The author has no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2022;19(10–12):8–9. Dear Editor: Patients exposed to second-generation antipsychotics (SGAs) are at approximately 10 times greater risk of developing diabetic ketoacidosis (DKA), compared to the general population.1 […]
Letter to the Editor: Steroid Management in a Patient with Myasthenia Gravis Undergoing COVID-19 Vaccination
Funding/financial disclosures. The authors have no conflict of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2022;19(7–9):8. Dear Editor: We report the case of a 70-year-old patient affected by ocular myasthenia gravis (MG), diagnosed three years ago due to double vision […]
Letter to the Editor: Innovative Rehabilitation Technologies in the COVID-19 Era: Two Sides of the Same Coin
Funding/financial disclosures. The authors have no conflict of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2022;19(4–6):8–9. Dear Editor: In the neuroscience field, the last 10 years have been dominated by the “great mantra” of neuroplasticity. Researchers and clinicians wanted to have […]
Letter to the Editor: Orthognathic Surgery for Patients with Neurodevelopmental Disorders Requires Careful Decision-making by a Multidisciplinary Team
Funding/financial disclosures. The authors have no conflict of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2022;19(4–6):9–10. Dear Editor: In recent decades, the prevalence of neurodevelopmental disorders, including attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), has been increasing.1 Patients […]
Letter to the Editor: Elevated Level of CXCL13 in Nonenhancing Diffuse Primary Lymphoma of the Brainstem
Innov Clin Neurosci. 2021;18(10–12):8. Dear Editor: Primary central nervous system (CNS) lymphoma (pCNL) is a rare neoplasia predominantly of the brain. Histologically, most of these neoplasias are diffuse large B-cell lymphomas.1 Although the exact diagnosis requires pathological confirmation, magnetic resonance imaging (MRI) often shows characteristic results, such as enhancement.2 However, nonenhancing pCNL have been described […]
Letter to the Editor: Beyond Robotics and Virtual Reality: It’s Time to go Back to the Patient!
Dear Editor: There is great scientific activity regarding robotics, virtual reality (VR), telehealth, and digital medicine.1–2 A “mischievous” point of view could tell that they are running after the real life, like the poor boy’s finger in the Harlem Dam hole. Evidence-based medicine, cost/efficacy ratio, and consensus papers are trying to put the hat over […]
Letter to the Editor: Beware of Neuroleptic Malignant Syndrome in COVID-19 Pandemic
Dear Editor: I read with great interest the recent article by Buttar et al1 detailing fatal consequences of the chronic neuroleptic malignant syndrome (NMS) from the United States. The authors prescribed the challenges of treating psychiatric patients with the possibility of NMS. They also indicated that ethnic groups concerning metabolic enzyme polymorphisms for antipsychotics, such […]
Letter to the Editor: Adjunct Ketamine in Electroconvulsive Therapy
Dear Editor: Electroconvulsive therapy (ECT) is a medical treatment that involves the electrical stimulation of the brain under general anesthesia. This treatment modality has been utilized worldwide for over 80 years.1 According to the American Psychiatric Association, ECT is indicated for major depression, mania, and schizophrenia.2 Unfortunately, there are occasions in which a psychiatrist is […]
